Home vaccine
 

Keywords :   


Tag: vaccine

Merck Animal Health introduces first injectable Ileitis vaccine

2015-09-17 21:38:35| National Hog Farmer

Merck Animal Health is pleased to introduce PORCILIS ILEITIS, the first injectable vaccine that offers a 20-week duration of immunity (DOI) for control of ileitis caused by Lawsonia intracellularis. Ileitis can significantly impact the health and performance of finishing pigs; curbing average daily gain by 38 percent and feed efficiency by 27 percent. read more

Tags: health animal introduces vaccine

 

Adults need more than just the annual flu vaccine

2015-09-15 08:42:24| Biotech - Topix.net

You're over 21. You're not a kid anymore. When fall arrives, why would reasonably healthy grown-ups need vaccinations? Well, there's the coming flu season, for one.

Tags: the annual adults flu

 
 

Are You Prepared for PEDv? Zoetis Ready to Bring Vaccine to Europe

2015-08-14 02:00:00| ThePigSite - Industry News

EUROPE - Showing its commitment to supporting European pig farmers and veterinarians, Zoetis is making its Porcine Epidemic Diarrhoea (PED) virus vaccine available to the European market.

Tags: to europe ready bring

 

Novavax: Early study indicates its vaccine effective vs. RSV

2015-08-11 03:06:09| Biotech - Topix.net

Early research in older adults found an experimental vaccine prevented nearly two-thirds of serious cases of a common, seasonal respiratory virus that annually kills thousands of vulnerable Americans - babies and senior citizens. If further testing by vaccine developer Novavax Inc. goes well, in a few years the biotech company's genetically engineered shot could become the first vaccine approved against respiratory syncytial virus, or RSV.

Tags: study early effective vs

 

Novavax: Early study indicates its vaccine effective vs. RSV

2015-08-11 03:06:08| Biotech - Topix.net

Early research in older adults found an experimental vaccine prevented nearly two-thirds of serious cases of a common, seasonal respiratory virus that annually kills thousands of vulnerable people - babies and senior citizens. If further testing by vaccine developer Novavax Inc. goes well, in a few years the biotech company's genetically engineered shot could become the first vaccine approved against respiratory syncytial virus, or RSV.

Tags: study early effective vs

 

Sites : [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] next »